Click here to return to the Reference Table

Category: Carcinomas
Descriptor: Animal models

Reference Number: 979
Jeffers M, Rong S, Anver M, Vande Woude GF. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells. Oncogene. 13, 853-6 (1996)
PubMed link      E-mail link

Reference Number: 1013
Hay RV, Cao B, Skinner RS, Wang LM, Su Y, Resau JH, Vande Woude GF, Gross MD. Radioimmunoscintigraphy of tumors autocrine for human met and hepatocyte growth factor/scatter factor. Mol Imaging. 1, 56-62 (2002)
PubMed link      E-mail link

Reference Number: 1254
Kakkar T, Ma M, Zhuang Y, Patton A, Hu Z, Mounho B. Pharmacokinetics and safety of a fully human hepatocyte growth factor antibody, AMG 102, in cynomolgus monkeys. Pharm Res. 24, 1910-8 (2007)
PubMed link      E-mail link

Reference Number: 1846
Hultberg A, Morello V, Huyghe L, De Jonge N, Blanchetot C, Hanssens V, De Boeck G, Silence K, Festjens E, Heukers R, Roux B, Lamballe F, Ginestier C, Charafe-Jauffret E, Maina F, Brouckaert P, Saunders M, Thibault A, Dreier T, de Haard H, Michieli P. Depleting MET-Expressing Tumor Cells by ADCC Provides a Therapeutic Advantage over Inhibiting HGF/MET Signaling. Cancer Res. 75, 3373-83 (2015)
PubMed link      E-mail link